• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素和替考拉宁抗生素后效应的体外比较。

In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.

作者信息

Cooper M A, Jin Y F, Ashby J P, Andrews J M, Wise R

机构信息

Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1990 Aug;26(2):203-7. doi: 10.1093/jac/26.2.203.

DOI:10.1093/jac/26.2.203
PMID:2145256
Abstract

The post-antibiotic effect (PAE) of teicoplanin was compared with that of vancomycin for five selected Gram-positive cocci. Two concentrations of each antibiotic were investigated, with the test organisms being exposed to each for both 1 and 2 h. At a concentration of 25 mg/l, teicoplanin had a greater PAE than vancomycin for the methicillin resistant staphylococci and Enterococcus faecalis strains tested. At a concentration of 5 mg/l, teicoplanin gave equal effects to those of vancomycin except for the strain of methicillin-resistant Staphylococcus aureus (MRSA) tested. The variation in the antibiotic exposure time gave only small changes in the PAE, except for the MRSA tested.

摘要

比较了替考拉宁和万古霉素对五种选定革兰氏阳性球菌的抗生素后效应(PAE)。研究了每种抗生素的两种浓度,将受试微生物分别暴露于这两种浓度下1小时和2小时。在25mg/l的浓度下,替考拉宁对所测试的耐甲氧西林葡萄球菌和粪肠球菌菌株的PAE比万古霉素更大。在5mg/l的浓度下,除了所测试的耐甲氧西林金黄色葡萄球菌(MRSA)菌株外,替考拉宁的效果与万古霉素相当。除了所测试的MRSA菌株外,抗生素暴露时间的变化仅使PAE发生微小变化。

相似文献

1
In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.万古霉素和替考拉宁抗生素后效应的体外比较。
J Antimicrob Chemother. 1990 Aug;26(2):203-7. doi: 10.1093/jac/26.2.203.
2
[In vitro activity of vancomycin and teicoplanin against gram-positive cocci].[万古霉素和替考拉宁对革兰氏阳性球菌的体外活性]
Pathol Biol (Paris). 1992 May;40(5):461-5.
3
In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.替考霉素A2与青霉素和万古霉素相比对革兰氏阳性球菌的体外活性。
Eur J Clin Microbiol. 1982 Oct;1(5):278-81. doi: 10.1007/BF02019971.
4
[Distribution and antibiotic resistance analysis of Gram positive cocci in bloodstream infections in a hospital in Inner Mongolia].[内蒙古某医院血流感染中革兰阳性球菌的分布及耐药性分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Aug 6;58(8):1242-1246. doi: 10.3760/cma.j.cn112150-20231120-00354.
5
Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.采用时间杀菌法对万古霉素或替考拉宁联合庆大霉素针对肠球菌、金黄色葡萄球菌及凝固酶阴性葡萄球菌进行协同研究。
J Med Assoc Thai. 1991 Dec;74(12):669-74.
6
Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.替考拉宁、万古霉素及其他抗菌药物的抗葡萄球菌活性:耐甲氧西林的意义
J Infect Dis. 1986 Aug;154(2):349-52. doi: 10.1093/infdis/154.2.349.
7
Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.替考拉宁在沙特阿拉伯利雅得的抗葡萄球菌活性。
APMIS Suppl. 1988;3:68-70.
8
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.金黄色葡萄球菌和肠球菌属暴露于替考拉宁、万古霉素、利奈唑胺和奎奴普丁-达福普汀后耐药性选择的体外比较评估
Clin Microbiol Infect. 2008 Jun;14(6):608-11. doi: 10.1111/j.1469-0691.2008.01993.x. Epub 2008 Apr 5.
9
[Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].[万古霉素、替考拉宁和利奈唑胺对儿科血培养中耐甲氧西林凝固酶阴性葡萄球菌分离株的活性]
Rev Esp Quimioter. 2012 Mar;25(1):25-30.
10
Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.凝固酶阴性葡萄球菌中替考拉宁和万古霉素耐药菌株的百分比及分布情况。
Antimicrob Agents Chemother. 1990 May;34(5):899-900. doi: 10.1128/AAC.34.5.899.

引用本文的文献

1
Pharmacokinetics and pharmacodynamics of peptide antibiotics.肽类抗生素的药代动力学和药效学。
Adv Drug Deliv Rev. 2022 Apr;183:114171. doi: 10.1016/j.addr.2022.114171. Epub 2022 Feb 18.
2
Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.MX-2401 的抗菌特性,一种在肺表面活性剂存在下具有广谱活性的脂肽。
Antimicrob Agents Chemother. 2011 Aug;55(8):3720-8. doi: 10.1128/AAC.00322-11. Epub 2011 May 16.
3
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.
替考拉宁:对其用于治疗革兰氏阳性菌感染的药物经济学评价
Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.
4
In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis.万古霉素对金黄色葡萄球菌和表皮葡萄球菌药效学特性的体外研究。
Antimicrob Agents Chemother. 1998 Oct;42(10):2739-44. doi: 10.1128/AAC.42.10.2739.
5
Parenteral aminoglycoside therapy. Selection, administration and monitoring.肠外氨基糖苷类药物治疗。选择、给药及监测。
Drugs. 1994 Jun;47(6):902-13. doi: 10.2165/00003495-199447060-00004.
6
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.替考拉宁:对其抗菌活性、药代动力学特性及治疗效果的重新评估
Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008.
7
Teicoplanin in perspective. A critical comparison with vancomycin.
Pharm Weekbl Sci. 1991 Aug 23;13(4):153-60. doi: 10.1007/BF01957739.
8
Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response.通过使用曲线剥离程序来描述浓度与药效学反应之间的关系,对葡萄球菌属进行万古霉素时间杀菌研究分析。
Antimicrob Agents Chemother. 1992 Aug;36(8):1766-9. doi: 10.1128/AAC.36.8.1766.